Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Clinical trial NCT01265940 · COMPLETED

Trial details

NCT number: NCT01265940
Sponsor: Prof. Dr. Thomas Otto
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.

Start date: 2011-03-01
Primary completion: 2012-01-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.